Skip to content

Vasopressin Deficiency in Hemorrhagic Shock

Vasopressin Deficiency in Hemorrhagic Shock

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01107314
Enrollment
81
Registered
2010-04-20
Start date
2010-02-28
Completion date
2011-04-30
Last updated
2018-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Response to Trauma

Brief summary

In this study we hope to delineate the typical vasoactive mediator response of trauma patients to shock. We plan to assess serum levels of vasopressin and also catecholamines, angiotensin, and cortisol during resuscitation of trauma patients to delineate high risk populations for vasopressin deficiency.

Detailed description

This is a prospective observational study. The only research-driven procedure will be the removal of blood samples at designated time points(total blood removed 48 cc per patient). Hemodynamic, fluid infusion and agitation/pain data (RAMSEY Score) will prospectively be collected for research purposes. We will collect data from a convenience sample of patients (when research staff is available) over a one year period.

Interventions

OTHERPhlebotomy

Blood draws (total 48 cc blood)

Sponsors

The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 98 Years
Healthy volunteers
No

Inclusion criteria

* Patient is a male or female patient presumed to be at least 18 years of age; * Patient has a reported or actual systolic blood pressure \< 90 mmHg within 1 hour of arrival to the Emergency Room; * Patient has clinical evidence of acute traumatic injury;

Exclusion criteria

* Patient is asystolic or requires CPR prior to arrival; * Patient was transferred from an outside facility * Patient known to be pregnant * Patient known to be prisoner

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026